HOME >> MEDICINE >> NEWS
New study shows weight loss decreases ACE enzyme that controls blood pressure

CHAPEL HILL -- People who find it hard to lose all the weight they want or that their doctors recommend should take heart, a University of North Carolina at Chapel Hill scientist says. New research suggests that losing even modest amounts of weight can pay off in better health.

The study showed for the first time that shedding excess pounds decreases activity of a key enzyme known to play a central role in high blood pressure, said Dr. Joyce Harp, associate professor of nutrition and medicine at the UNC schools of public health and medicine. Less body weight translates into lower blood pressure, the study confirmed, and hence lower risks for cardiovascular disease, stroke, kidney disease and other health problems.

Published in the current (October) issue of the journal Obesity Research, the investigation was conducted at Emory University in Atlanta where Harp previously worked.

"We intensively studied 16 obese but otherwise healthy, non-diabetic adults on the clinical research unit," said Harp, "Our goal was to determine if blood pressure regulating enzymes and hormones that are produced in fatty tissue are lowered by modest dietary weight loss."

After first conducting studies in rodents, which demonstrated that all the components of the renin-angiotensin system were produced in fat tissue, Harp and colleagues extended their work to humans, she said. Volunteers were supplied with calorie-restricted, defined diets that enabled them to lose modest amounts of weight, about 5 to 10 percent.

Researchers found that in addition to significant decreases in blood pressure, angiotensin-converting enzyme (ACE) activity was suppressed most dramatically with weight loss, she said. Plasma renin activity and serum aldosterone levels also declined, but those changes were not as great as the drop in ACE activity.

ACE activity while standing up, which Harp and the others showed for the first time is higher than when lying down, declined
'"/>

Contact: David Williamson
919-962-8596
University of North Carolina at Chapel Hill
22-Oct-2002


Page: 1 2 3

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
(Date:5/21/2013)... Boston, Mass.By studying the roles two proteins, thrombospondin-1 ... trans-Atlantic research team has identified a five-amino acid ... in mouse models of prostate, breast and lung ... could potentially block metastasis in a variety of ... Randolph Watnick, PhD, at Boston Children,s Hospital, Vivek ...
(Date:5/21/2013)... May 21, 2013 The nation’s first ... is nearing its conclusion in Washington state court, ... closing statements yesterday, an attorney for the Plaintiffs compared ... wanted to tie sales and services for its customers. ... to keep control of surgeons, to keep control of ...
(Date:5/21/2013)... A new study appearing in the ... stem cells harvested from fat (adipose) are more potent ... modulate the body’s immune system. , The finding ... as adipose tissue-derived stem cells (AT-SCs) are far more ... marrow and can be collected from waste material from ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Less is more ... severe bouts of chronic obstructive pulmonary disease (COPD), according ... with prednisone to treat COPD flare-ups was as good ... for adverse side effects, they said. "We wanted ... not less effective than 14 days," said lead researcher ...
(Date:5/21/2013)... of Iowa,s vice president for research and economic ... computing, the next generation of supercomputers designed to ... the human mind. , Daniel Reed will appear ... the House Subcommittee on Energy, titled, "America,s Next ... at 10 a.m. in Room 2318 of the ...
Breaking Medicine News(10 mins):Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3Health News:Iowa VP for Research addresses next-generation supercomputers at congressional hearing 2
(Date:5/21/2013)... May 21, 2013 On its tenth ... product developments at the Special Libraries Association PHTD meeting in ... focus on product literature databases and workflow solutions for the ... said founding director Nigel Johnson . "At ... to our clients and what better forum to announce them ...
(Date:5/21/2013)... 21, 2013 /PRNewswire-iReach/ -- The 2013 Pharma ChemOutsourcing Show ... the greatest number of "Emerging" small molecule biotech ... Mark Alexay .  "No one saw this ... year.  The show,s still 4 months away and we ... a big surprise and great news for attendees". Thecurrent ...
(Date:5/21/2013)... 2013  Decision Resources, one of the ... pharmaceutical and healthcare issues, finds that the ... efficacy endpoints, including overall survival and time ... over surveyed U.S. and European oncologists, prescribing ... breast cancer. The two novel emerging therapies ...
Breaking Medicine Technology:Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2
Cached News: